Trial Summary
What is the purpose of this trial?The purpose of the study is to develop and test innovative interventions to prevent the development of opioid misuse and opioid use disorders among older adolescents and young adults (AYA; ages 16-30) who use opioids, which will be initiated from a health care visit in the emergency department and extended post discharge via a telehealth approach. This study will have significant impact by identifying optimal, cost-effective opioid prevention strategies to sustain outcomes among AYAs.
Eligibility Criteria
This trial is for young people aged 16-30 who visit a Michigan Medicine emergency department, can communicate in English, and are able to consent. They must have used prescription opioids and have at least one risk factor like drug misuse or depression. Pregnant individuals, those with recent injection drug use, acute sexual assault victims, suicidal individuals, or current cancer patients are excluded.Inclusion Criteria
Seeking care in Michigan Medicine emergency department (ED)
I am mentally capable of understanding and agreeing to participate.
I use prescription opioids and have at least one other risk factor or misuse opioids.
+2 more
Exclusion Criteria
I am currently dealing with an acute sexual assault, feeling acutely suicidal, or am diagnosed with/receiving treatment for cancer.
You have used injection drugs in the past year.
Current pregnancy at baseline
+2 more
Participant Groups
The study tests prevention strategies for opioid misuse among older adolescents and young adults using brief interventions (BI), a portal system for follow-up care, and enhanced usual care (EUC). It aims to identify cost-effective methods that prevent the development of opioid use disorders after an emergency department visit.
4Treatment groups
Experimental Treatment
Active Control
Group I: Enhanced Usual Care (EUC) then PortalExperimental Treatment2 Interventions
EUC will be delivered at intake and the portal will occur for 4 weeks starting at intake.
Group II: Brief intervention (BI) then PortalExperimental Treatment2 Interventions
The BI will be delivered at intake and the portal will occur for 4 weeks starting at intake.
Group III: Brief intervention (BI) then Enhanced Usual Care (EUC)Experimental Treatment2 Interventions
The BI will be delivered at intake and EUC will be added 4 weeks later.
Group IV: Enhanced Usual Care (EUC) then EUCActive Control1 Intervention
EUC will be delivered at intake and delivered again 4 weeks later.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
University of MichiganAnn Arbor, MI
Loading ...
Who Is Running the Clinical Trial?
University of MichiganLead Sponsor
National Institute on Drug Abuse (NIDA)Collaborator